{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:42Z","timestamp":1740124242408,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Renin\u2013angiotensin system hyperactivation in autosomal-dominant polycystic kidney disease (ADPKD) patients leads to early hypertension. Cystic enlargement probably causes parenchymal hypoxia, renin secretion, and endothelial dysfunction. Sympathetic and parasympathetic balance is altered in this condition, especially during the night, also affecting blood pressure circadian rhythm. Aim of this study was to evaluate sympathetic\/parasympathetic balance using heart rate variability (HRV) parameters and find a correlation between HRV and renal damage progression, as total kidney volume enlargement, in ADPKD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixteen adult ADPKD patients were enrolled in the study. Eleven patients (68.8%) were male, and the median age was 42\u00a0years (IQR 36\u201347.5). HRV parameters were calculated using 24\u00a0h-ECG Holter. A kidney magnetic resonance imaging (MRI) scan 3 Tesla was performed to evaluate total kidney volume (TKV) and total fibrotic volume (TFV).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A statistically significant positive linear correlation was observed between length of kidneys and frequency domain parameters as low frequency (LF) (<jats:italic>r<\/jats:italic>\u2009=\u20090.595, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and LFday (<jats:italic>r<\/jats:italic>\u2009=\u20090.587, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Moreover, a statistically significant positive linear correlation exists between high frequency (HF) and TFV (<jats:italic>r<\/jats:italic>\u2009=\u20090.804, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) or height-adjusted (ha) TFV (<jats:italic>r<\/jats:italic>\u2009=\u20090.801, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Finally, we found a statistically significant positive linear correlation between HFnight and TKV (<jats:italic>r<\/jats:italic>\u2009=\u20090.608, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), ha-TKV (<jats:italic>r<\/jats:italic>\u2009=\u20090.685, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), TFV (<jats:italic>r<\/jats:italic>\u2009=\u20090.594, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and ha-TFV (<jats:italic>r<\/jats:italic>\u2009=\u20090.615, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We suppose that the increase in TKV and TFV could lead to a parasympathetic tone hyperactivation, probably in response to hypoxic stress and vasoconstriction due to cystic enlargement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11255-023-03551-y","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:03:56Z","timestamp":1681308236000},"page":"3153-3158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-2954","authenticated-orcid":false,"given":"Silvia","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo Marco","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Tinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Muscaritoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"3551_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","volume":"67","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Torres VE (2016) Autosomal dominant polycystic kidney disease: core curriculum 2016. Am J Kidney Dis 67:792\u2013810. https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.037","journal-title":"Am J Kidney Dis"},{"key":"3551_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","volume":"98","author":"B Porath","year":"2016","unstructured":"Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K et al (2016) Mutations in GANAB, encoding the glucosidase iialpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193\u20131207. https:\/\/doi.org\/10.1016\/j.ajhg.2016.05.004","journal-title":"Am J Hum Genet"},{"key":"3551_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1681\/asn.2016121312","volume":"28","author":"OR Cabezas","year":"2017","unstructured":"Cabezas OR, Flanagan SE, Stanescu H, Garcia-Martinez E, Caswell R, Lango-Allen H et al (2017) Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2. J Am Soc Nephrol 28:2529\u20132539. https:\/\/doi.org\/10.1681\/asn.2016121312","journal-title":"J Am Soc Nephrol"},{"key":"3551_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","volume":"109","author":"SR Senum","year":"2022","unstructured":"Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S et al (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet 109:136\u2013156. https:\/\/doi.org\/10.1016\/j.ajhg.2021.11.016","journal-title":"Am J Hum Genet"},{"key":"3551_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000343281","volume":"36","author":"I Helal","year":"2012","unstructured":"Helal I, Reed B, Mettler P, Mc Fann K, Tkachenko O, Yan XD et al (2012) Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol 36:362\u2013370. https:\/\/doi.org\/10.1159\/000343281","journal-title":"Am J Nephrol"},{"key":"3551_CR6","first-page":"806","volume":"20","author":"E Rahman","year":"2009","unstructured":"Rahman E, Niaz FA, Al-Suwaida A, Nahrir S, Bashir M, Rahman H et al (2009) Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl 20:806\u2013810","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3551_CR7","doi-asserted-by":"publisher","first-page":"8458","DOI":"10.26355\/eurrev_202008_22643","volume":"24","author":"S Lai","year":"2020","unstructured":"Lai S, Bagordo D, Perrotta AM, Gigante A, Gasperini ML, Muscaritoli M et al (2020) Autonomic dysfunction in kidney diseases. Eur Rev Med Pharmacol Sci 24:8458\u20138468. https:\/\/doi.org\/10.26355\/eurrev_202008_22643","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3551_CR8","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.26355\/eurrev_202110_27005","volume":"25","author":"S Lai","year":"2021","unstructured":"Lai S, Perrotta AM, Bagordo D, Mazzaferro S, Men\u00e8 P, Gigante A et al (2021) Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients. Eur Rev Med Pharmacol Sci 25:6333\u20136338. https:\/\/doi.org\/10.26355\/eurrev_202110_27005","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3551_CR9","first-page":"299","volume":"13","author":"E Buccelletti","year":"2009","unstructured":"Buccelletti E, Gilardi E, Scaini E, Galiuto L, Persiani R, Biondi A et al (2009) Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur Rev Med Pharmacol Sci 13:299\u2013307","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3551_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/imj.14039","volume":"48","author":"S Lai","year":"2018","unstructured":"Lai S, Mastroluca D, Letizia C, Petramala L, Perrotta AM, DiGaeta A et al (2018) Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease. Intern Med J 48:1505\u20131513. https:\/\/doi.org\/10.1111\/imj.14039","journal-title":"Intern Med J"},{"key":"3551_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"M Malik","year":"1996","unstructured":"Malik M (1996) Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93:1043\u20131065","journal-title":"Circulation"},{"issue":"Suppl 113","key":"3551_CR12","first-page":"24","volume":"36","author":"A Gigante","year":"2018","unstructured":"Gigante A, Margiotta D, Navarini L, Liberatori M, Barbano B, Tubani L et al (2018) Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis. Clin Exp Rheumatol 36(Suppl 113):24\u201327","journal-title":"Clin Exp Rheumatol"},{"key":"3551_CR13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/nep.13514","volume":"24","author":"YH Chou","year":"2019","unstructured":"Chou YH, Huang WL, Chang CH, Yang CCH, Kuo TBJ, Lin SL et al (2019) Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients. Nephrology (Carlton) 24:806\u2013813. https:\/\/doi.org\/10.1111\/nep.13514","journal-title":"Nephrology (Carlton)"},{"key":"3551_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/08037051.2012.680691","volume":"21","author":"O Orscelik","year":"2012","unstructured":"Orscelik O, Kocyigit I, Baran O, Kaya C, Dogdu O, Zengin H et al (2012) Impairment of heart rate recovery index in autosomal-dominant polycystic kidney disease patients without hypertension. Blood Press 21:300\u2013305. https:\/\/doi.org\/10.3109\/08037051.2012.680691","journal-title":"Blood Press"},{"key":"3551_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000013382","volume":"18","author":"G Cerasola","year":"1998","unstructured":"Cerasola G, Vecchi M, Mul\u00e8 G, Cottone S, Mangano MT, Andronico G et al (1998) Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives. Am J Nephrol 18:391\u2013398. https:\/\/doi.org\/10.1159\/000013382","journal-title":"Am J Nephrol"},{"key":"3551_CR16","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1681\/asn.2018090902","volume":"30","author":"MDA Van Gastel","year":"2019","unstructured":"Van Gastel MDA, Edwards ME, Torres VE, Erickson BJ, Gansevoort RT, Kline TL (2019) Automatic measurement of kidney and liver volumes from MR images of patients affected by autosomal dominant polycystic kidney disease. J Am Soc Nephrol 30:1514\u20131522. https:\/\/doi.org\/10.1681\/asn.2018090902","journal-title":"J Am Soc Nephrol"},{"key":"3551_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2016.04.170","volume":"217","author":"L Di Lullo","year":"2016","unstructured":"Di Lullo L, Rivera R, Barbera V, Bellasi A, Cozzolino M, Russo D et al (2016) Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies. Int J Cardiol 217:16\u201327. https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.170","journal-title":"Int J Cardiol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03551-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:18:54Z","timestamp":1698412734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03551-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3551"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03551-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the University Sapienza of Rome (N 6.1\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}